Stites E - Search Results

1

Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies.

Davis S, Gralla J, Klem P, Stites E, Wiseman A, Cooper JE. Davis S, et al. Among authors: stites e. Transplantation. 2020 Apr;104(4):881-887. doi: 10.1097/TP.0000000000002913. Transplantation. 2020. PMID: 32224815

2

Multiorgan transplantation.

Stites E, Wiseman AC. Stites E, et al. Transplant Rev (Orlando). 2016 Oct;30(4):253-60. doi: 10.1016/j.trre.2016.04.002. Epub 2016 Jul 17. Transplant Rev (Orlando). 2016. PMID: 27515042 Review.

3

Current status of pancreas transplantation.

Stites E, Kennealey P, Wiseman AC. Stites E, et al. Curr Opin Nephrol Hypertens. 2016 Nov;25(6):563-569. doi: 10.1097/MNH.0000000000000264. Curr Opin Nephrol Hypertens. 2016. PMID: 27653421 Review.

4

Live donor kidney - PAK versus SPK: how to decide?

Stites E, Wiseman AC. Stites E, et al. Curr Opin Organ Transplant. 2017 Aug;22(4):377-381. doi: 10.1097/MOT.0000000000000435. Curr Opin Organ Transplant. 2017. PMID: 28538038 Review.

5

Defining kidney allograft benefit from successful pancreas transplant: separating fact from fiction.

Wiseman AC, Stites E, Kennealey P. Wiseman AC, et al. Among authors: stites e. Curr Opin Organ Transplant. 2018 Aug;23(4):448-453. doi: 10.1097/MOT.0000000000000547. Curr Opin Organ Transplant. 2018. PMID: 29878910 Review.

6

Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.

Jalal D, Renner B, Laskowski J, Stites E, Cooper J, Valente K, You Z, Perrenoud L, Le Quintrec M, Muhamed I, Christians U, Klawitter J, Lindorfer MA, Taylor RP, Holers VM, Thurman JM. Jalal D, et al. Among authors: stites e. J Am Heart Assoc. 2018 Jul 13;7(14):e007818. doi: 10.1161/JAHA.117.007818. J Am Heart Assoc. 2018. PMID: 30006493 Free PMC article.

7

Complement fragments are biomarkers of antibody-mediated endothelial injury.

Stites E, Renner B, Laskowski J, Le Quintrec M, You Z, Freed B, Cooper J, Jalal D, Thurman JM. Stites E, et al. Mol Immunol. 2020 Feb;118:142-152. doi: 10.1016/j.molimm.2019.12.011. Epub 2019 Dec 26. Mol Immunol. 2020. PMID: 31884386 Free PMC article.

8

High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.

Stites E, Kumar D, Olaitan O, John Swanson S, Leca N, Weir M, Bromberg J, Melancon J, Agha I, Fattah H, Alhamad T, Qazi Y, Wiseman A, Gupta G. Stites E, et al. Am J Transplant. 2020 Sep;20(9):2491-2498. doi: 10.1111/ajt.15822. Epub 2020 Mar 10. Am J Transplant. 2020. PMID: 32056331 Free PMC article.

9

Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort.

Davis S, Wiebe C, Campbell K, Anobile C, Aubrey M, Stites E, Grafals M, Pomfret E, Nickerson P, Cooper JE. Davis S, et al. Among authors: stites e. Am J Transplant. 2021 Jan;21(1):322-328. doi: 10.1111/ajt.16290. Epub 2020 Oct 11. Am J Transplant. 2021. PMID: 32888256 Free PMC article.

10

Untangling the Clinical and Methodological Assessment of Risks Associated With BK Nephropathy.

Stites E, Cooper JE, Schold JD. Stites E, et al. Kidney Int Rep. 2023 Jan 28;8(3):401-402. doi: 10.1016/j.ekir.2023.01.027. eCollection 2023 Mar. Kidney Int Rep. 2023. PMID: 36938076 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page